rs12903401
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000711326.1(ENSG00000292375):n.352G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 501,760 control chromosomes in the GnomAD database, including 52,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 13946 hom., cov: 32)
Exomes 𝑓: 0.46 ( 38652 hom. )
Consequence
ENSG00000292375
ENST00000711326.1 non_coding_transcript_exon
ENST00000711326.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.402
Publications
12 publications found
Genes affected
ANKRD34C-AS1 (HGNC:48618): (ANKRD34C antisense RNA 1)
MIR184 (HGNC:31555): (microRNA 184) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of target mRNAs. This microRNA represents the most abundant miRNA in the corneal and lens epithelia of the eye and has been shown to interfere with target binding by another miRNA, miR-205. Through regulation of the VEGF and Akt signaling pathways, this microRNA may inhibit corneal angiogenesis. Mutations in the seed region of this microRNA cause familial keratoconus with cataract, also known as EDICT syndrome. [provided by RefSeq, Mar 2017]
MIR184 Gene-Disease associations (from GenCC):
- EDICT syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 15-79209754-G-C is Benign according to our data. Variant chr15-79209754-G-C is described in ClinVar as Benign. ClinVar VariationId is 1223338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.536 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENSG00000292375 | ENST00000711326.1 | n.352G>C | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||||
| ANKRD34C-AS1 | ENST00000559225.3 | n.470+3433C>G | intron_variant | Intron 2 of 2 | 4 | |||||
| ANKRD34C-AS1 | ENST00000560872.1 | n.178-17652C>G | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.406 AC: 61592AN: 151888Hom.: 13937 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
61592
AN:
151888
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.464 AC: 115006AN: 247820 AF XY: 0.462 show subpopulations
GnomAD2 exomes
AF:
AC:
115006
AN:
247820
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.461 AC: 161409AN: 349756Hom.: 38652 Cov.: 0 AF XY: 0.453 AC XY: 89226AN XY: 197054 show subpopulations
GnomAD4 exome
AF:
AC:
161409
AN:
349756
Hom.:
Cov.:
0
AF XY:
AC XY:
89226
AN XY:
197054
show subpopulations
African (AFR)
AF:
AC:
1996
AN:
10020
American (AMR)
AF:
AC:
19360
AN:
35810
Ashkenazi Jewish (ASJ)
AF:
AC:
5686
AN:
11194
East Asian (EAS)
AF:
AC:
7091
AN:
12440
South Asian (SAS)
AF:
AC:
23513
AN:
64162
European-Finnish (FIN)
AF:
AC:
15126
AN:
31528
Middle Eastern (MID)
AF:
AC:
1298
AN:
2582
European-Non Finnish (NFE)
AF:
AC:
80384
AN:
167006
Other (OTH)
AF:
AC:
6955
AN:
15014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
3966
7933
11899
15866
19832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.405 AC: 61610AN: 152004Hom.: 13946 Cov.: 32 AF XY: 0.409 AC XY: 30358AN XY: 74306 show subpopulations
GnomAD4 genome
AF:
AC:
61610
AN:
152004
Hom.:
Cov.:
32
AF XY:
AC XY:
30358
AN XY:
74306
show subpopulations
African (AFR)
AF:
AC:
8138
AN:
41464
American (AMR)
AF:
AC:
8043
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1694
AN:
3466
East Asian (EAS)
AF:
AC:
2848
AN:
5152
South Asian (SAS)
AF:
AC:
1756
AN:
4818
European-Finnish (FIN)
AF:
AC:
5031
AN:
10578
Middle Eastern (MID)
AF:
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32655
AN:
67942
Other (OTH)
AF:
AC:
948
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1777
3553
5330
7106
8883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1463
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.